Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase I
Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of…
Clinical
Deciphera’s investigational GIST drug ripretinib granted priority review by FDA
Clinical
Eisai complies with FDA request to pull weight-loss drug Belviq from…
Clinical
FDA grants priority review to Bristol-Myers Squibb’s filing for liso-cel in…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Acerus Announces Private Placement and Refinancing Transactions
Commercial
Following Clinical Hold and Trial Setback, Ipsen Takes $728 Million Hit…
Commercial
Indivior Full Year 2019 Results Now Available; Leadership Presentation Today
Deals
Sensorion Announces the Full Conversion of Sofinnova Partners Convertible Bonds Into…
Home
Commercial
Deals
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Deals
Deals
Sensorion Announces the Full Conversion of Sofinnova Partners Convertible Bonds Into Ordinary Shares
Biospace News
-
February 13, 2020
Deals
Evgen Pharma University of Rochester Collaboration
Firstwordpharma News
-
February 13, 2020
Deals
Rosalind Franklin University Announces Research Collaboration With Exicure
Firstwordpharma News
-
February 13, 2020
0
Deals
BenevolentAI announces scientific collaboration with UC San Diego to investigate Cerebral...
Firstwordpharma News
-
February 12, 2020
0
Deals
Sihuan Pharmaceutical and Hetero Labs Limited Reached A Framework Cooperation Agreement...
Firstwordpharma News
-
February 12, 2020
0
Deals
Sirtex Medical announces collaboration with MIM Software Inc.
Firstwordpharma News
-
February 12, 2020
0
Deals
Luye Pharma Grants Cipla Medpro Exclusive Distribution and Marketing Rights for...
Firstwordpharma News
-
February 11, 2020
0
1
2
3
...
143
Page 1 of 143
- Advertisement -
LATEST NEWS
Scandion Oncology receives final approval from the Danish Medicines Agency for start of clinical Phase II trial in patients with drug resistant metastatic colorectal...
Firstwordpharma News
-
November 29, 2019
0
Seattle Genetics Announces Progress in Expanding ADCETRIS (Brentuximab Vedotin) Indications in Canada
May 3, 2019
Abeona Therapeutics to Present Data for ABO-401 in Cystic Fibrosis and Retinal Disorders at the American Society of Gene and Cell Therapy Annual Meeting
April 15, 2019
MUST READ
How Much Did These Pharma CEOs Earn in 2017?
Biospace News
-
May 2, 2019
0
ADVANZ PHARMA Corp. Announces Release Date for First Quarter 2019 Results
Biospace News
-
April 26, 2019
0
Spring Bank Announces Research Agreement with The National Institute of Allergy and Infectious Diseases...
Firstwordpharma News
-
July 18, 2019
0
Load more
